In the Australian–NZ Registry, only 38.6% (n = 182/505) of SCAD patients underwent FMD screening [6], while in the Japanese cohort, 39.6% (n = 25/63) had FMD screening [18]. The gene discussed is FLNA; the disease is spontaneous coronary artery dissection.